Trial intelligence / Profile preview

Propofol vs Dexmedetomidine for Emergence Agitation in LDLT

NCT02544906Unknown

Start
Sep 2015
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol injection (veterinary) and dexmedetomidine in Emergence agitation (EA) (3 arms). Primary endpoint: Incidence of emergence agitation at 24 hours. Status: unknown.

02

Drugs

propofol injection (veterinary)dexmedetomidine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT02544906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02544906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call